Breaking news – Pagina 144 – AMD

Breaking news

Dicembre 29, 2023 dario.olivero

Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial

Zoungas S, Zhou Z, Owen AJ, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00327-3.

Leggi

Dicembre 21, 2023 dario.olivero

Once‐weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis

Kobo O, Cavender MA, Jensen TJ, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.

Leggi

Dicembre 21, 2023 dario.olivero

Current status and principles for the treatment and prevention of diabetic foot ulcers in the cardiovascular patient population: a scientific statement from the american heart association

Gallagher KA, Mills JL, Armstrong DG, et al.
Circulation. Pub. online 14 Dec 2023.

Leggi

Dicembre 21, 2023 dario.olivero

Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials

Munshi M, Ritzel R, Jude EB, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.

Leggi

Dicembre 21, 2023 dario.olivero

Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors

Rizzi A, Kloecker DE, Pitocco D, et al.
NMCD. Pub. online 19 Dec 2023.

Leggi

Dicembre 21, 2023 dario.olivero

Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

Wu J, Zhou R, Zhang Q, et al.
Diabetes Obes Metab. Pub. online 15 Dec 2023.

Leggi

Dicembre 21, 2023 dario.olivero

A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: a pilot study

Colosimo S, Martínez-Sánchez MA, Balaguer-Román A, et al.
NMCD. Pub. online, 16 Dec 2023.

Leggi

Dicembre 14, 2023 dario.olivero

Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy

Cesta CE, Rotem R, Bateman BT, et al.
JAMA Intern Med. 2023:e236663.

Leggi

Dicembre 14, 2023 dario.olivero

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial

Aronne LJ, Sattar N, Horn DB, et al.
JAMA. 2023:e2324945.

Leggi

Dicembre 11, 2023 dario.olivero

Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies

Igweokpala S, Sule NO, Douros A, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.

Leggi